SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-22-028231
Filing Date
2022-11-30
Accepted
2022-11-30 19:27:32
Documents
1
Period of Report
2022-11-30

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 3163
  Complete submission text file 0001437749-22-028231.txt   4640
Mailing Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017
Business Address 4995 BRADENTON AVENUE SUITE 240 DUBLIN OH 43017 6147937500
NAVIDEA BIOPHARMACEUTICALS, INC. (Issuer) CIK: 0000810509 (see all company filings)

IRS No.: 311080091 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 4995 BRADENTON AVE SUITE 240 DUBLIN OH 43017
Business Address
Witter Malcolm G (Reporting) CIK: 0001838283 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-35076 | Film No.: 221436781